While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
1d
Stockhead on MSNHealth Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agentBrazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.
Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO ... headaches), isometheptene (a sympathomimetic amine with vasoconstriction properties) and dichloralphenazone ...
It’s been two years since Aminé’s last album, Kaytraminé, which was a collaboration with Kaytranada. Today, the Portland rapper is sharing a preview of its followup with the new song ...
Aminé is officially in album mode. After clearing his Instagram earlier in the week to drop an influx of new album-related content, the rapper has returned with his first new single of 2025. Enti ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
The new generation of hydrogels moves away from the bulk materials of old, to those with multilayered, complex internal structures and controllable physical properties. You have full access to ...
Balaji Amines Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 3,910.64 Crore) operating in Chemicals sector. Balaji Amines Ltd. key Products/Revenue Segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results